153 related articles for article (PubMed ID: 38314969)
1. Tracing topics and trends in drug-resistant epilepsy research using a natural language processing-based topic modeling approach.
Karabacak M; Jagtiani P; Jain A; Panov F; Margetis K
Epilepsia; 2024 Apr; 65(4):861-872. PubMed ID: 38314969
[TBL] [Abstract][Full Text] [Related]
2. Natural language processing reveals research trends and topics in The Spine Journal over two decades: a topic modeling study.
Karabacak M; Margetis K
Spine J; 2024 Mar; 24(3):397-405. PubMed ID: 37797843
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Degenerative Cervical Myelopathy Research Landscape: Topic Modeling of the Literature.
Karabacak M; Jagtiani P; Zipser CM; Tetreault L; Davies B; Margetis K
Global Spine J; 2024 May; ():21925682241256949. PubMed ID: 38760664
[TBL] [Abstract][Full Text] [Related]
4. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
Challal S; Skiba A; Langlois M; Esguerra CV; Wolfender JL; Crawford AD; Skalicka-Woźniak K
J Ethnopharmacol; 2023 Dec; 317():116740. PubMed ID: 37315641
[TBL] [Abstract][Full Text] [Related]
5. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
[TBL] [Abstract][Full Text] [Related]
6. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
7. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
[TBL] [Abstract][Full Text] [Related]
10. From Text to Insight: A Natural Language Processing-Based Analysis of Topics and Trends in Neurosurgery.
Karabacak M; Schupper AJ; Carr MT; Hickman ZL; Margetis K
Neurosurgery; 2024 Apr; 94(4):679-689. PubMed ID: 37988054
[TBL] [Abstract][Full Text] [Related]
11. Exploiting Natural Language Processing to Unveil Topics and Trends of Traumatic Brain Injury Research.
Karabacak M; Jain A; Jagtiani P; Hickman ZL; Dams-O'Connor K; Margetis K
Neurotrauma Rep; 2024; 5(1):203-214. PubMed ID: 38463422
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of drug resistant epilepsy in children.
Kumar G
Curr Probl Pediatr Adolesc Health Care; 2021 Jul; 51(7):101035. PubMed ID: 34305005
[TBL] [Abstract][Full Text] [Related]
13. Rufinamide add-on therapy for drug-resistant epilepsy.
Panebianco M; Prabhakar H; Marson AG
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
[TBL] [Abstract][Full Text] [Related]
14. Drug-resistant epilepsy: Drug target hypothesis and beyond the receptors.
Fonseca-Barriendos D; Frías-Soria CL; Pérez-Pérez D; Gómez-López R; Borroto Escuela DO; Rocha L
Epilepsia Open; 2022 Aug; 7 Suppl 1(Suppl 1):S23-S33. PubMed ID: 34542940
[TBL] [Abstract][Full Text] [Related]
15. How much can medical management alone improve the outcome of adult drug-resistant epilepsy? An exploratory study on possibilities and limitations of combining multiple therapeutic actions.
Serafini R
Epilepsy Behav; 2021 Sep; 122():108065. PubMed ID: 34243142
[TBL] [Abstract][Full Text] [Related]
16. Drug resistant epilepsy and associated factors among children with epilepsies in tanzania: a cross-sectional study.
Urio OH; Kija E; Weckhuysen S; Makungu H; Naburi H
BMC Neurol; 2024 Jan; 24(1):8. PubMed ID: 38166885
[TBL] [Abstract][Full Text] [Related]
17. Rufinamide add-on therapy for refractory epilepsy.
Panebianco M; Prabhakar H; Marson AG
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
[TBL] [Abstract][Full Text] [Related]
20. Current trends and hotspots in drug-resistant epilepsy research: Insights from a bibliometric analysis.
Ni XJ; Zhong H; Liu YX; Lin HW; Gu ZC
Front Neurol; 2022; 13():1023832. PubMed ID: 36408494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
